Predict your next investment

Pulmed Pharma company logo
HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Series C | Alive

Total Raised


Last Raised

$31M | 14 days ago

About Pulmed Pharma

Pulmed Pharma, also Chance or Hangzhou Changxi, is a drug development company that focuses on dry powder inhalation drug delivery systems and generic drugs for alleviating chronic obstructive pulmonary disease and improved drugs for treating asthma.

Pulmed Pharma Headquarter Location

3F, Block C, Future Research and Innovation Park No. 7 Longtan Road, Yuhang District

Hangzhou, Zhejiang ,


+86 0571-86108179

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pulmed Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pulmed Pharma is included in 2 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.



5,881 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.